News
-
ACLA Files Appeal in ACLA v. Azar, Asks U.S. Court of Appeals to Address HHS’s Overreach in Data Reporting
HHS’s continued flawed implementation of PAMA threatens beneficiaries’ access to critical lab services Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) advanced its case against the U.S. Department of Health and Human Services’ (HHS) flawed and harmful implementation of the Protecting Access to Medicare Act (PAMA). ACLA’s opening brief argues that HHS has exceeded its statutory authority, circumventing Congress’ stated directive ofContinue Reading »... -
ACLA Appellant/Petitioner Brief: American Clinical Laboratory Association v. Alex Azar
... -
In a divided Washington, protecting seniors’ health care is an issue where everyone agrees
As lawmakers work to advance final legislative proposals, Congress has the chance to take decisive action on one issue that has bipartisan support: protecting seniors’ access to essential, life-saving lab services. Recognizing the critical role of routine testing for patient health and overall cost savings, more than 30 organizations representing patients, health care professionals, laboratories and diagnostic manufacturers are calling on Congress to takeContinue Reading »... -
ACLA Memo Regarding Anti-Kickback provisions of the SUPPORT for Patients and Communities Act (Public Law 115-271)
... -
ACLA Statement on Final 2019 Medicare Payment Policies
Final rule takes preliminary steps to correct flawed data collection process; urgent Congressional action needed to protect millions of seniors from continued cuts to essential Medicare lab services Washington, D.C. – Following the release of final Medicare payment policies, Julie Khani, President of the American Clinical Laboratory Association (ACLA) issued the following statement regarding new policy changes related to implementation of the Protecting AccessContinue Reading »... -
ACLA Letter on the Request for Information Regarding the Anti-Kickback Statute and Beneficiary Inducement CMP
... -
ACLA Statement on Notice of Appeal in ACLA v. Azar
HHS’s continued reliance on faulty data collection process jeopardizes access to critical lab tests for millions of beneficiaries; ACLA files appeal following District Court decision Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) filed its notice of appeal in its lawsuit against the U.S. Department of Health and Human Services (HHS) challenging its implementation of the Protecting Access to Medicare Act (PAMA),Continue Reading »... -
ACLA Letter to Michigan Medicaid on Cystic Fibrosis Testing
... -
ACLA Comments on CY 2019 OPPS Proposed Rule
... -
ACLA Statement on District Court Opinion in Lawsuit Against HHS
Lawsuit targeted HHS’ unlawful implementation of 2014 Medicare legislation, regulatory guidance that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – Following the opinion from the U.S. District Court for the District of Columbia in ACLA v. Azar, Julie Khani, ACLA President, issued the following statement: “This is an extremely disappointing outcome for ACLA’s members and the millions of seniors they serveContinue Reading »...
